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ABSTRACT
We have developed a Lewis-acid catalyzed, diastereoselective aza-Cope rearrangement—
Mannich cyclization to form acyl pyrrolidines from conformationally mobile substrates. In
earlier studies from our lab, Brønsted acid-catalyzed reactions to form the same acyl
pyrrolidines resulted in diastereoselectivities of 8:1 trans to cis at elevated temperatures (60
°C) over the course of 150 minutes. We have demonstrated an improvement in our method
yielding exclusively the trans isomers at ambient temperature with substoichiometric
amounts of BF3•OEt2 within 3 minutes. Catalyst loadings as low as 0.05 equivalents of
BF3•OEt2 initiate this transformation. Our synthetic method employs the oxazolidine starting
material as a mixture of diastereomers to produce one pyrrolidine diastereomer. Both ethyland substituted phenyl-oxazolidines were successfully rearranged. This work is the first
example of a truly catalytic aza-Cope—Mannich reaction and provides the first examples of
diastereoselective syntheses of 2-phenyl-4-acylpyrrolidines via this reaction.
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I. Introduction
Acyl pyrrolidine scaffolds are important structural motifs for a number of valuable
pharmaceuticals and natural products. The unnatural amino acid β-proline (1) is one of the
least complex examples of this motif and is utilized in anti-selective Mannich reactions1
(Figure 1). More functionalized pyrrolidines are used as target specific antibiotics such as
anisomycin (2), an antifungal and amoebicide2, 3. Darifenacin (3), a commercially marketed
drug, is an effective M₃ muscarinic receptor antagonist used to inhibit contractions that result
in an overactive bladder. 4

Figure 1. Novel targets employing acyl pyrrolidines as scaffolds
As the activity of these compounds is highly dependent on both their absolute and
relative stereochemistries, the development of a useful synthetic pathway to these targets
hinges on the stereoselectivity of the method. This has been a challenge in the past;5,6
however, we have developed an efficient, diastereoselective synthetic pathway to acyl
pyrrolidines from conformationally mobile systems.

II. Literature Review
Our synthetic design employs the aza-Cope-rearrangement—Mannich cyclization of
oxazolidines to acyl pyrrolidines, originally pioneered by Overman7. A mixture of
oxazolidine diastereomers 4 is treated with a Lewis acid (Scheme 1). The acid coordination
activates the ring, which ionizes to form iminium cation intermediate 5. Intermediate 5 then
undergoes a 3,3-sigmatropic rearrangement to form iminium cation 6 followed by a ring
closure to form acyl pyrrolidine diastereomers 7 and 8.
Scheme 1

A. Aza-Cope—Mannich vs aza-Prins—pinacol
There are two mechanistic pathways that could form an acyl pyrrolidine from an
iminium cation: the aforementioned aza-Cope rearrangement—Mannich cyclization and the
aza-Prins—pinacol rearrangement could, in principle, produce the observed acyl pyrrolidines
(Scheme 2). The aza-Cope rearrangement begins when iminium cation A undergoes a 3,3sigmatropic rearrangement to form the second iminium cation B. The Mannich cyclization
occurs when the enol/enolate moiety of iminium cation B then cyclizes onto the carbon of the
iminium cation B to form acyl pyrrolidine D. For the aza-Prins pathway, once the iminium
cation is formed the C-C double bond cyclizes onto the iminium cation to form piperidyl
cation C. The carbocation then undergoes a pinacol rearrangement (a 1,2-alkyl shift along
with formation of the carbonyl) to form acyl pyrrolidine D or piperidone E.
2

Scheme 2

Several investigators have sought to discern which mechanism is operating. Jacobsen,
Levin, and Overman8 attempted to distinguish between the two by studying the reaction of
enantioenriched oxazolidine 9 (Scheme 3) as well as incorporating electron withdrawing or
donating substituents on the vinyl group of a cyclic-amino alcohol (vide infra).
Scheme 3

Enantioenriched oxazolidine 9 was treated with camphorsulphonic acid (CSA) for 1.5
hours at 60 ºC (Scheme 3). The enantiomeric excess for oxazolidine 9 was not reported,
however the authors estimated the enantiopurity of the starting oxazolidine 9 to be greater
3

than 90% by NMR analysis of a Mosher amide derived from the oxazolidine prior to its Nmethylation. Chromatography and recrystallization yielded a single diastereomer 10 that was
found to be racemic. From this racemization, the authors concluded that the aza-Cope—
Mannich (ACM) mechanism was operating rather than the aza-Prins—pinacol. It was argued
by the authors that racemization in the ACM could be expected if the reaction proceeded
through an achiral intermediate and if C-C bond rotation occurred prior to the Mannich
cyclization (Scheme 4, G → H). Furthermore, racemization could not occur in the azaPrins—pinacol (E → F → 10) because intermediate F would maintain chirality during ring
formation.
Scheme 4

Overman also made chemical modifications to the substrate that produced evidence
of an aza-Cope—Mannich mechanism8. For this study, the location of the functional group
probe was set to the position of the carbocation that would be formed in an aza-Prins
mechanism (13, Scheme 5). By placing a strong electron withdrawing substituent in this
position the carbocation would become destabilized which would likely slow the aza-Prins
4

reaction. By contrast, a substituent at this position would have less effect on an aza-Cope
reaction (11, Scheme 5). It is important to point out that this study was conducted under the
assumption that the aza-Cope/aza-Prins is the rate determining step of the reaction.
Scheme 5

Overman observed that the reaction went to completion for all substrates with the
exception of the sulfonyl-substituted substrate (Entry 7, Table 1). After subjecting the amino
alcohol to 1.1 eq. AgNO3 in ethanol at room temperature, they isolated pyrrolidine 15a and
the oxazolidine 15b in 20% and 40% yields respectively. They then attempted to increase the
yield of 15a with the use of silver triflate (Entry 8) only to isolate the oxazolidine
intermediate 15b. The unsubstituted amino alcohol also required heat and extended reaction
time to reach completion (Entry 3). When run using conditions analogous to other successful
reactions, epimerization at the α-position occurred (yield not reported, Entry 2). The methyl
and thioether-substituted amino alcohols gave the highest yield (Entries 1 and 4).

5

Table 1. Electronic effects on the rearrangement of amino alcohol 14 to pyrrolidine 15a
When the ethoxy-substituted amino alcohol was treated with 1.1 eq AgNO3 in ethanol
at room temperature, nucleophilic trapping of the solvent occurred to give perhydroquinoline
15d (Entry 5). Formation of this product requires that the amino alcohol convert to the azaPrins intermediate 15c through an iminium ion-alkene cyclization (Scheme 6).
Scheme 6

6

Attempts were made to initiate pinacol rearrangement of 15d to 15a with both acidic
and basic conditions. However, hydrolysis to the corresponding ketone rendered these
attempts unsuccessful. When treated with silver triflate in ether the ethoxy-substituted amino
alcohol converted to a complex mix of products. After purification 15a was isolated in 37%
yield (Entry 6, Table 1).
A similar study was conducted by Armstrong and Shanahan9 in their approach to 7azabicyclo[2.2.1]heptanes (Table 2). They screened several acids and found that 1 equivalent
of SnCl4 initiated the rearrangement of N-tosyl protected α-alkoxy-pyrrolidines to 7azabicyclo[2.2.1]heptane 17. When 2 equivalents of SnCl4 were used, the product underwent
a ring expansion to the [3.2.1]tropanone 18. To differentiate between aza-Cope and aza-Prins
pathways the investigators used electron donating or withdrawing substituents on the same
internal carbon of the vinyl group, as was the case in Overman’s investigation, to probe rate
changes.

7

Table 2. Electronic effects on intramolecular cyclization to form a bicyclic system.

Two of the electron donating substituents (Entries 1 and 2, Table 2) gave good
yields in the eight minute time period as would be expected; however the unsubstituted
(Entry 3) and cyclohexenyl-substituted (Entry 6) substrates gave moderate to low yields.
The quick reaction time and low yield of the electron donating thioether-substituted substrate
(Entry 4) was due to the fact that the molecule very rapidly formed tropane 18, even in the
presence of a single equivalent of SnCl4. The investigators also found that sulfonylsubstituted amino alcohol resulted in cyclization to form oxazolidine 20 (Scheme 7).
Overman had observed a similar conversion of a sulfonyl-substituted amino alcohol to
oxazolidine prior to submitting it to CSA in refluxing benzene (cf. Table 1).

8

Scheme 7

It is curious that in both investigations, when submitted to the standard reaction
conditions, the compounds with sulfonyl substituents rearrange to the oxazolidines 15b and
20. Overman’s oxazolidine 15b was formed at room temperature within an hour after
treatment with silver triflate at room temperature. Similarly, Armstrong et al. treated their
starting material with SnCl4 at 0 ºC for 8 minutes and also isolated oxazolidine (20). Both
unsubstituted compounds also displayed sluggish reaction times (Table 1, Entry 3 and
Table 2, Entry 3). Overman’s reaction took 19 hours at 40 ºC to yield 64% of pyrrolidine
15a. Similarly, Armstrong et al. required 14.5 hours at 20 ºC to yield 32% of pyrrolidine 17.
Both studies exhibited excellent yields for the methyl substituent as well (Table 1, Entry 1
and Table 2, Entry 2). While the data reported in each publication is very similar, each
author came to a different conclusion. Overman suggested that the aza-Cope—Mannich
mechanism was operating while Armstrong suggested aza-Prins—pinacol as a rational for
the products formed. In summary, these observations do not clearly differentiate between the
aza-Cope and aza-Prins pathways across all systems. Overman confirmed the aza-Cope—
Mannich was in operation through the observed racemization of enantioenriched oxazolidine
9. However, this did not necessarily translate to the bicyclic system, as evidenced by the
isolation of the aza-Prins product (Entry 5, Table 1).

9

In systems without an allylic alcohol, the aza-Prins operates without pinacol
rearrangement. Padrόn et al.10 found that tosylated iminium cation 21 (Scheme 8) yielded a
mix of piperidine diastereomers 23 and 24 after nucleophilic addition of chloride ion onto the
aza-Prins piperidyl cation intermediate 22.
Scheme 8

.
What is striking about this halogen trapping is the fact that the nucleophile is introduced not
just from the Lewis acid but from the solvent as well. The investigators formed this
conclusion when they observed a mixture of bromo and chloro piperidines after FeBr3 was
introduced as the Lewis acid in dichloromethane and also when FeCl3 was used in
dibromomethane (Table 3). This unique observation could be exploited in the future to
distinguish between the aza-Prins and aza-Cope mechanisms. Should the halogen trapping of
the piperidyl cation be faster than a pinacol reaction in systems with an allylic alcohol, the
isolation of this side product would point to an aza-Prins pathway. However, the absence of
this product cannot be a definitive marker for the aza-Cope pathway.

10

Table 3. Halogen trapping of piperidyl cations by Lewis acid and solvent in systems without
allylic alcohols.
To date, no definitive studies have been published that distinguish between azaCope—Mannich and aza-Prins—pinacol pathways. The studies by both Overman and
Armstrong rely heavily on the assumption that the aza-Cope/aza-Prins is the rate determining
step of the reaction. Overman asserts that the racemization of pyrrolidine from
enantioenriched starting material requires the transformation through an achiral intermediate
as well as C-C bond rotation prior to Mannich cyclization. This racemization would not be
observed in an aza-Prins rearrangement due to the inability of C-C bond rotation to occur
after ring formation. Armstrong relies heavily on the absence of rearrangement in the case of
the sulfonyl group as evidence of the aza-Prins pathway. It is possible that the aza-Prins may
be discerned by halogen trapping from Lewis acid and solvent; however, as stated before the
absence of this product cannot lead to a final conclusion. From the subsequent studies it is
apparent that rearrangement is highly acid dependent. The evidence previously presented to
differentiate between both mechanisms is largely inconclusive.
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B. Aza-Cope—Mannich reaction of small, conformationally mobile systems
Several attempts have been made to optimize selectivity of the aza-Cope—Mannich
in small, conformationally mobile systems. Historically, variations of this reaction have
exhibited excellent stereocontrol in large, rigid systems11,12. However, in smaller
conformationally mobile systems erosion of that control can occur through C-C bond
rotations prior to or following the aza-Cope rearrangement or from acid-catalyzed
epimerization of the products.
In 1983 Overman, Kakimoto, Okazaki and Meier5 synthesized a variety of substituted
4-acylpyrrolidines. The reactions were initiated by condensing 2-methoxy-(or hydroxy)-2methyl-3-butenamine 29 or ammonium salt 30 with an aldehyde in refluxing benzene or
toluene (Scheme 9). Two procedures were developed to produce the final product. Either the
tetrafluoroborate salt of the amine was directly condensed with the aldehyde, or the free
amine was condensed with the aldehyde along with 0.9 equivalents of CSA to yield acyl
pyrrolidine 31.
Scheme 9
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In only one case were the investigators able to achieve a high yield with 0.1
equivalents of acid. The reaction supports a variety of substituents with good yields;
however, their reaction was limited to reactive, unhindered aldehydes (Entries 1-4, Table 4)
and amino ethers. Less reactive aldehydes and ketones such as pivaldehyde, cyclohexanone
and 3-pentanone (Entries 6-12) required the isolation of the oxazolidine intermediate 33 in
order to form the desired product. Reactions using cylododecanone (Entry 11) and 3pentanone (Entry 12) presented the poorest yields. For the synthesis of 2-phenyl-pyrrolidine
(Entry 5) the diastereoselectivity was reported as 2:1, however the major isomer was not
identified.

Table 4. Demonstration of the scope of the aza-Cope—Mannich reaction to produce 2-alkyl4-acetylpyrrolidines
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Cooke, Bennett, and McDaid6 were able to expand on this research by adding
glyoxylic acid to α,β-amino allylic alcohol 35 (Scheme 10). The glyoxylic acid acts as both a
substituent and a Brønsted acid. The reaction conditions are mild, and no purification other
than rotary evaporation of the solvent was required to give 36 with an overall yield of 64%.
The major diastereomer observed was the trans isomer, which was confirmed with NOE
analysis. Unfortunately this diastereoselectivity was inconsistent and the trans to cis ratio
ranged from 4:1 – 24:1. However, the reaction conditions that generated these variations
were not specified.
Scheme 10

In 1994 Deng and Overman13 explored these losses, and mapped them on their way to
a total synthesis of preussin. The initial strategy was to form the enantio-pure pyrrolidine 40
by chirality transfer from (S)-phenylalanine and selective iminium cation formation (Scheme
11).

14

Scheme 11

Table 5. A stereoselective example of cis acyl pyrrolidines in the total synthesis of preussin.
When N-methyl oxazolidine 39 was refluxed in trifluoroacetic acid (TFA), a mix of
diastereomers 40 and 41 was formed (Entry 1, Table 5). However, when a similar 2º amine
was subjected to 0.9 equivalents of CSA in trifluoroethanol at room temperature for 40 hours,
only cis pyrrolidine 42 was obtained. The selectivity for pyrrolidine 40 improves slightly
with the addition of a benzyl-substituted oxazolidine (Entries 3 and 4). However, the overall
diastereoselectivity of the N-alkylated series is variable, whereas the 2º amine gives excellent
cis selectivity.
In a previous publication14, we attempted a microwave-assisted, one-pot aza-Cope—
Mannich reaction. Allylic amino alcohol 43 (Table 6) was treated with aldehyde, CSA and
15

copper sulfate to synthesize pyrrolidines 44a and 44b in good yields. Our own attempts to
utilize ethyl glyoxylate resulted in limited selectivity of 5:1 favoring the trans pyrrolidine,
somewhat consistent with Cooke et al.’s 4:1-24:1 selectivity (Entry 9). We observed
improved trans selectivities of 5:1-8:1 with benzhydryl as the R1 substituent regardless of the
R2 substituent (Entries 4, 5 and 11). We surmised that the sterics of the R1 N-protecting
group forms allylic strain with the R2 substituent, overcoming the 1,3 diaxial interactions,
favoring a trans pyrrolidine F (Scheme 12). We had observed in some cases that lowering
the temperature with increased reaction times lead to improved selectivities (Entries 4 and 5,
7 and 8, 10 and 11). An unpublished result (Entry 12) showed that at room temperature
selectivity increased from 8:1 to 13:1.
Scheme 12
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Table 6. Modest diastereoselectivity in a microwave assisted aza-Cope—Mannich formation
of acyl pyrrolidines.
More recently, Padrόn15 and associates were able achieve excellent selectivity with a
similar substrate utilizing FeCl3 at room temperature with 15 minute reaction times (Scheme
13). With their tosyl-protected amino alcohol, they were able to achieve 99:1 trans to cis
selectivity using a full equivalent of FeCl3 (Entries 1, 5-8, Table 7). With substoichiometric
amounts of FeCl3 they were able to achieve comparable selectivities (Entries 2, 4, 9 and 12).
Unfortunately, when 0.1 molar equivalent of FeCl3 was used, an additional full equivalent of
trimethylsilyl chloride (TMS-Cl) was required to recycle the catalyst.

17

Scheme 13

The selectivity for the trans isomer in this system can be rationalized as in the
previous case (Scheme 12). The major disadvantage to using these conditions is the fact that
the tosyl moiety prohibits aryl substituted-oxazolidines from reacting. In the case of a phenyl
substituent, no pyrrolidine product was observed, even with a full equivalent of FeCl3
(Entries 11 and 12).
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Table 7. Aza-Cope—Mannich reactions using stoichiometric and substoichiometric FeCl3
These previous attempts at a diastereoselective pyrrolidine synthesis have exhibited
several limitations. Cooke et al. was able to achieve excellent diastereoselectivity in some
cases, but with limited reproducibility within the same system. In this report, only a single
aldehyde substituent was used, but the novelty of this study is that it also acted as the
activating acid6. Overman was able to achieve rearrangement with large bulky ketones,
albeit with minimal selectivity5. Conditions required almost a full equivalent of acid, high
temperatures and 24 hour reaction times. Our own attempts yielded modest selectivities,
requiring an equivalent of Brønsted acid, as well as half an equivalent of copper sulfate and
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longer reaction times14. Deng and Overman illustrated the importance of steric interactions
with the N-protecting group to control diastereoselectivity13. This was further supported by
our own results when using the bulky benzhydryl moiety. This was again verified by Padrόn
et al. with the use of the large tosyl group, however the electronics of the tosyl moiety limited
the substituents to alkyl groups, preventing aryl substituents at the C-2 position15. Though
Padrόn was able to demonstrate catalytic amounts of Lewis acid to be successful, these
conditions required an additional equivalent of TMS-Cl to initiate catalyst turnover.
III. Results and Discussion
In light of the literature it is important to keep in mind that both aza-Cope—Mannich
and aza-Prins—pinacol pathways are possible. For our substrates, we cannot determine that
one mechanism is operating over the other. Nonetheless, the aza-Cope—Mannich is the
reaction that has typically been used to describe transformations that are similar to our own58, 12-16

. Thus these results are presented in the context of the aza-Cope—Mannich reaction.

A. Carbon-carbon bond rotation causes loss of stereochemistry
In an open, chair-like transition state, stereoselectivity may be lost through C-C bond
rotation (Scheme 14). Bond rotation may occur before or after the aza-Cope rearrangement.
If chair A undergoes ACM without rotation the acyl pyrrolidine II is formed. A bond
rotation may convert the chair A to boat B resulting in the cis acyl pyrrolidine III. Similarly,
three bond rotations can convert chair A to chair B, which would form the ent-trans acyl
pyrrolidine IV. Finally a post aza-Cope bond rotation, for example to boat A or chair C,
would result in the ent-cis acyl pyrrolidine I.

20

Scheme 14

Selectivity may also erode through iminium cation isomerization. To mitigate this,
use of an appropriate protecting group may favor one diastereomer over another (Scheme
15). The energy difference between iminium cation intermediates may be increased through
the manipulation of the allylic and 1,3 diaxial interactions of the amine protecting group with
the iminium cation substituent16. In the presence of a bulky substituent and a large protecting
group, a lower energy reactive conformation may be achieved through formation of chair D,
which will lead to trans pyrrolidine F after ACM. If a small protecting group is employed,
the 1,3 diaxial strain between the substituents overcomes the allylic interactions of the
protecting group and the adjacent substituent in the pseudo-equatorial position. Chair A is
then favored as the reactive conformation, leading to the cis pyrrolidine C. For the purpose of
this project we sought to apply these principles of iminium cation selectivity to synthesis of
21

2-ethyl and 2-phenyl acetyl pyrrolidines. To date, only a single synthesis of a 2-phenyl acetyl
pyrrolidine has been reported5. However, the diastereoselectivity in this case was very poor
(cf. Table 4, Entry 5).
Scheme 15

B. Discovery of a catalytic aza-Cope—Mannich
We began by synthesizing 2-ethyl-substituted N-benzhydryl oxazolidine 47 (Table 8)
by microwave-assisted condensation of the appropriate allylic amino alcohol and aldehyde in
the presence of 3Å molecular sieves. After chromatography, oxazolidine 47 was isolated as a
1.6:1 mix of diastereomers. Previously, we had screened several Lewis acids and found
BF3•OEt2 to give the best yields in our earlier systems. We found that we were able to
successfully perform the reaction with a full equivalent of Lewis acid (Entry 1) in 15
minutes to generate 48a in good yield. We attempted the reaction with 0.25 equivalents of
acid and observed the same result (Entry 2). We then used only 0.1 equivalents of acid
(Entry 3); however, we only observed 15% conversion of oxazolidine 47 to pyrrolidine 48a.
It should be noted that where >50:1 selectivity is indicated, no cis isomer was detected by 1H
NMR.
22

Table 8. Optimization of the Lewis acid catalyzed aza-Cope—Mannich reaction in the
synthesis of 2-ethyl acetyl pyrrolidine.
Having established an optimal catalyst loading of 0.25 equivalents of acid with the
ethyl-substituted oxazolidine 47, we attempted the same reaction with 2-phenyl-substituted
N-benzhydryl oxazolidine 49, which was present as a 1.71:1 mix of diastereomers (Table 9).
We subjected the mixture of oxazolidine diastereomers to a full equivalent of BF3•OEt2 and
allowed the reaction to proceed for 1 hour (Entry 1, Table 9). To our delight the reaction
went to completion and yielded a single isomer, the first example of stereoselective azaCope—Mannich to generate a 2-aryl-4-acyl pyrrolidine. We then performed the reaction
with 0.25 equivalent of BF3•OEt2 for 1 hour and found the same result. We also attempted
the use of 0.1 equivalent of BF3•OEt2 for 1 hour and found that the reaction went to
completion (Entry 3). To our knowledge, this is the first example of a catalytic,
diastereoselective aza-Cope—Mannich reaction. Once we had optimized the Lewis acid
catalyst loading, we began to test the rate of reaction. We found that we could perform the
reaction in 3 minutes with 0.25 equivalents of acid (Entry 2). We observed the reaction by
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NMR and found that the reaction was complete in 7 minutes using 0.05 equivalents of acid
(Entry 4).

Table 9. Optimization and discovery of a catalytic aza-Cope—Mannich pathway to 2-aryl
pyrrolidines.
C. Investigation of electronic effects on the aza-Cope—Mannich reaction
In light of these results, we wanted to determine why the ethyl-substituted
oxazolidine converted very slowly with 0.1 equivalents of catalyst (Entry 3, Table 8) while
the phenyl-substituted oxazolidine converted faster with that catalyst loading and with even
less catalyst (Entries 3 and 4, Table 9). In order to explore the scope of these findings, we
set out to perform a kinetic study to ascertain the reasons for these rate differences.
Unpublished computational studies17 of similar N-alkyl protected systems have shown that
the aza-Cope rearrangement is the rate determining step of the ACM sequence. We set out to
observe this experimentally by synthesizing a number of substituted aryl oxazolidines to
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submit to our optimized conditions (0.25 equivalents of BF3•OEt2 in 0.5M CH2Cl2 at ambient
temperatures).
Substitution at the para position demonstrates resonance effects, whereas substitution
at the meta position demonstrates inductive effects (Table 10). When the acid activates the
ring, iminium cation B is formed. The sp3 carbon between the oxygen and nitrogen of
oxazolidine A would be expected to exhibit a strong partial positive charge leading toward a
formal cation in the transition state. The unsubstituted aryl group would stabilize this by an
electron donating inductive effect. Should the iminium cation formation be the rate
determining step of the reaction, electron withdrawing substituents (Entries 2, 4-8) will act
to increase the speed of reaction through inductive destabilization of the reactive sp3 carbon
center. By contrast, the electron donating methoxy- and methyl-substituted aryl groups could
stabilize the electron deficient carbon, thereby slowing the reaction.

Table 10. Predictions on the electronic and inductive effects of substituents on the rates of
iminium cation formation, aza-Cope rearrangement and Mannich cyclization.
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If the aza-Cope rearrangement is the rate determining step, we predict that electron
donating substituents (Entries 2,4-8) will act to stabilize iminium cation B (Table 10)
resulting in a decrease in the rate of reaction. Resonance withdrawing substituents will act to
destabilize the iminium cation B which will act to increase the rate of the 3,3 sigmatropic
shift and consequently the overall rate of reaction. If the Mannich cyclization is the rate
determining step then there should be no appreciable change in rate as the iminium cation C
results in a partial positive charge too far away to be significantly affected by the electronic
effects of either meta or para substituents.
With predictions in mind, we began our study by synthesizing the necessary
oxazolidine intermediates via a microwave-assisted synthesis (Table 11). Those oxazolidines
with a resonance electron donating methoxy substituent (61) and inductive electron donating
methyl substituents (63 and 64) required longer reaction times. By contrast, those containing
electron withdrawing substituents (66 – 69) required significantly shorter reaction times.
Early on, we encountered some decomposition of some of the oxazolidines during silica gel
chromatography. This could be suppressed by adding 1% triethylamine to the
chromatography solvent system (Entries 4-7, Table 11, see experimental section for details).
In addition, in some cases, co-elution of unreacted aldehyde with the oxazolidine during
column chromatographic separations required the addition of NaBH4 to the reaction mixture.
Resulting reduction of the aldehyde to the corresponding alcohol increased differences in
retention times and facilitated successful separations (Entries 3-7, Table 11, see
experimental section for details).
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Table 11. Optimization of microwave assisted synthesis of oxazolidine intermediates from
amino alcohol18.
We subjected each mixture of oxazolidine diastereomers to 0.25 equivalents of
BF3•OEt2 for 12 hours in order to ascertain if pyrrolidine selectivity was maintained in all
systems (Table 12). Curious results occurred with the introduction of the electron
withdrawing nitro group at both the para and meta positions (Entries 7 and 8). Selectivity
degraded somewhat from >50:1 favoring trans to cis to a ratio of 18:1. As noted earlier,
where >50:1 selectivity is indicated, no cis isomer was detected by 1H NMR (Entries 1-4, 6
and 9). Similarly, the introduction of the para-chloro substituent in oxazolidine 74 also
degraded selectivity, but marginally to 36:1 (Entry 5). Surprisingly, the same reduction in
selectivity was not observed for the meta-chloro substituted pyrrolidine 75.
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Table 12. Diastereoselectivity in the formation of acyl pyrrolidines substituted with aryl
groups of varying electronic demand.
In addition to pre and post aza-Cope C-C bond rotation, stereoselectivity may erode
through epimerization after Mannich cyclization. There are two possible ways for
epimerization to occur once the Lewis acid has coordinated to the carbonyl of the pyrrolidine
(Scheme 16). The first is a retro-Mannich opening of pyrrolidine A to iminium cation B.
Once the ring has opened it may either undergo C-C bond rotation and cyclize to form a
mixture of pyrrolidine diastereomers A and E. It may also continue to revert through the azaCope rearrangement C, undergo C-C bond rotation and proceed back through the azaCope—Mannich to form E. The second way for epimerization to occur is through keto/enol
tautomerism of the ketone. Once the Lewis acid coordinates to A, deprotonation of the
adjacent hydrogen can occur, leading the enolate intermediate D. Addition of the hydrogen
may occur on either face, again leading to a mix of diastereomers A and E.
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Scheme 16

Throughout our studies, we observed variability in selectivity of the para-nitro
substituted system with respect to time (Table 13). It is possible that due to the reversibility
of the Mannich cyclization, we are observing epimerization via one of the pathways
described above (Scheme 16). When we allowed the reaction to proceed for 15-17 hours,
trans to cis selectivity of 76a:76b ranged from 15:1-21:1 (Entries1-3, Table 13). The two
trials that ran for 12 hours varied quite a bit, with selectivities of 20:1 and 12:1 (Entries 4
and 5). Trials run between 25 minutes and 1 hour ranged from 8:1 to 10:1 (Entries 6-8). We
ran one trial reacting 5 vessels in tandem that were quenched with sodium bicarbonate
solution at varying time points up to 3 minutes (Entries 9-13). From this trial it appears that
trans selectivity was greatest within the first 3 minutes of reaction but at the expense of
conversion. However, the extent of consistency within this time frame is unknown since
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these reactions were only run once. With these results in mind, we recommend the reaction
be terminated as soon as possible to yield the greatest selectivity.

Table 13. Variability of diastereoselectivity with reaction time in the formation of p-nitrophenyl acyl pyrrolidine.
In order to monitor reaction rates, we developed a kinetics experiment using the
JEOL Delta software. Reaction vessels were set up as described in the experimental section
in the general procedure for the preparation of 1-(1-benzhydryl-5-(R)pyrrolidin-3yl)ethanones and an aliquot was transferred via cannula to a dried NMR tube under nitrogen
atmosphere. The tube was transferred to the instrument and gradient shimmed. Initial trials
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indicated very fast reaction times. In fact, many had gone to completion as soon as the first
scan was taken. We attempted to dilute our Lewis acid and introduce it directly to an NMR
tube, bypassing the time required to transfer an aliquot to the tube. This however was
unsuccessful. We were able to monitor a few reactions, however we encountered
reproducibility issues likely related to the incompatibility of our Lewis acid with humid lab
conditions as well logistical issues related to the very fast speeds of reaction. We then
changed our method to a timed quench method. Again, several reaction vessels were set up
as described in the general procedures in the experimental section. All conditions were kept
constant with time as the variable. The Lewis acid was introduced to the reaction vessel and
each reaction mixture was quenched with saturated sodium bicarbonate after a reaction time
of 1, 5, 30, 60 or 180 seconds. Despite these detailed, careful efforts, a high amount of
variability was observed at each time point, which left us unable to draw any conclusions
from the data we had accrued. To demonstrate these inconsistencies, in the case of the paratoluene-substituted acyl pyrrolidine, the extent to which the reaction went to completion
varied a great deal (Table 14). In the first trial, we observed little to no rearrangement within
5 seconds (Entries 1 and 2). However, we saw a maximum conversion at 30 seconds (Entry
3) and were disappointed to see no greater conversion after 3 minutes (Entry 5). We
attempted a second trial, but saw minimal conversion to product (Entry 2). Again, at 30
seconds (Entry 3) we saw higher conversion, but the results between trials after 3 minutes
were completely different, and strangely, showed less conversion than reactions run for less
time (Entry 5). In the third trial we saw little conversion within 30 seconds (Entries 1-3).
Adding to these inconsistencies, trial 3 showed almost complete conversion after 3 minutes.
Many of these reactions had gone to completion within 3 minutes during studies using the
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previous NMR method. We would expect this to remain consistent; however, as seen in
Entry 5 alone there is a large variability between reactions run for 3 minutes.

Table 14: Challenges with reproducibility: p-toluene-substituted oxazolidine conversion
during implementation of the quenching method.
Initially we attempted to dilute our reaction mixture in an effort to slow the reaction
(Entries 1-3, Table 15). However, the reaction showed at least 50% conversion within the
first minute. We then attempted to cool the reaction to 0 °C (Entries 4-10). Within the first
minute we had surpassed our target of less than 10% conversion. We then attempted to cool
the reaction to -20 °C with dry ice and ethylene glycol (Entry 11) the reaction converted
1.5% in ten minutes but never continued thereafter. Dilution of the reaction mixture and
cooling to -10 °C resulted in 4% conversion; this reaction also failed to proceed further after
the first aliquot was taken (Entry 10). Due to the high speed of reaction, and variability of
results the kinetic study of the N-benzhydryl system was abandoned.
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Table 15: Strategies to optimize conditions for kinetic studies of the aza-Cope—Mannich
cyclization of an unsubstituted 2-phenyl-N-benzhydryl protected system.
IV. Conclusion
Through manipulation of an appropriate N-protecting group, we have developed a
diastereoselective synthetic pathway to acyl pyrrolidines from conformationally mobile
starting materials. In previous studies from our lab using similar N-benzhydryl intermediates
we were able to achieve diastereoselectivities of 8:1 trans to cis at elevated temperatures (60
°C) over the course of 150 minutes. In this work, we have demonstrated an improvement in
our method, resulting in primarily trans isomers at ambient temperature with
substoichiometric amounts of BF3•OEt2 within 3 minutes. Catalyst loadings as low as 0.05
equivalents of BF3•OEt2 initiate this transformation. Our synthetic method employs the
oxazolidine starting materials as mixtures of diastereomers to produce one pyrrolidine
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diastereomer. Both ethyl- and a number of substituted phenyl- oxazolidines were successfully
rearranged. Significantly, this is the first example of a diastereoselective aza-Cope—
Mannich reaction to produce 2-aryl-4-acyl-pyrrolidines.
Unfortunately, strongly electron deficient aryl substituents at the C2 position exhibit
small reductions in diastereoselectivity. A better understanding of the future challenges with
respect to stereocontrol depends upon the relative rates of each step within the reaction
sequence. In order to address these issues in our own smaller mobile systems, we had sought
to elucidate the rate-determining step of the ACM through reaction of a series of oxazolidines
bearing aromatic electron donating and withdrawing substituents. However, due to the rapid
rate of reaction for all these substrates, we were unable to adequately monitor this reaction by
NMR or traditional quenching methods. Several unsuccessful attempts were made to slow
reaction progression by diluting the reaction mixtures as well as cooling reactions to sub-zero
temperatures. In the future, slower reactions will be required to observe substituent effects at
the C2 position in the aza-Cope—Mannich pathway.
There is always the possibility that the aza-Prins—Pinacol mechanism is operating in
the formation of the products we have observed. During our studies we did not observe
nucleophilic trapping of a 6-membered intermediate that would indicate such a mechanism.
However, the absence of this product cannot be considered conclusive evidence of an azaCope mechanism. Other factors could mitigate the isolation of a trapped piperidyl cation.
For example, the pinacol rearrangement may be faster than trapping by an external
nucleophile or a viable external nucleophile may not exist under our reaction conditions. At
any rate, if the aza-Prins—pinacol is the operating mechanism in systems with this particular
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substitution pattern, the mechanism is insignificant to the synthetic utility of the reaction;
both mechanisms would be expected to yield the same trans selective product.
V. Experimental
General procedures
All commercially available compounds were purchased from Sigma-Aldrich, Alpha
Aesar, or Strem Chemical Companies and used as received unless otherwise specified.
Methylene chloride was distilled from calcium hydride. Boron trifluorido-diethyl etherate
(BF3•OEt2)was distilled from calcium hydride. Purification of compounds by flash
chromatography was performed using silica gel (40-75 μm particle size, 60 Å pore size).
TLC analyses were performed on silica gel 60 F254 plates (250 μm thickness). Microwaveassisted reactions were performed using a CEM DiscoverTM reactor. All 1H NMR and 13C
NMR spectra were obtained on a 400 MHz JEOL ECX instrument and chemical shifts (δ)
reported relative to residual solvent peak CHCl3. All NMR spectra were obtained at room
temperature.
General procedure for the preparation of 1-(1-benzhydryl-5-(R)pyrrolidin-3yl)ethanones: All oxazolidines were dried over activated silica with distilled methylene
chloride and concentrated to yield a clear oil prior to reaction. To a flame-dried round
bottom flask was added 3Å molecular sieves (150.0 mg) and oxazolidine (0.500 mmol).
Under inert gas atmosphere, freshly distilled dichloromethane (4 mL) was added. The
solution was allowed to stir for one hour. Freshly distilled BF3•OEt2 (0.0177 g, 0.125 mmol)
was added using a gastight syringe and allowed to stir for 15-60 minutes. The reaction was
quenched with saturated sodium bicarbonate solution, extracted 3 times with
dichloromethane, dried over MgSO4 and concentrated.
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General conditions for kinetic studies by 1H NMR: JEOL Delta software was set to
monitor the reaction in non-deuterated methylene chloride with a gain value of 14-16. The X
offset was 2 ppm with an X sweep range of 6ppm. The X angle was set to 45°. A total of
2048 points were scanned at 4 scans/15 seconds with a relaxation delay of 1s. Two hundred
and forty time points were collected to yield a total collection time of 61:18 minutes.
3-benzhydryl-5-methyl-2-ethyl-5-vinyloxazolidine [47]
To a microwaveable test tube was added 3Å molecular sieves (150.0 mg). The tube
was charged with amino alcohol 60 (750 mg, 2.81 mmol) and propionaldehyde (163 mg, 2.81
mmol). The vial was sealed with a reusable cap and then placed into the microwave reactor.
The reaction was carried out with the following input parameters: 300 watts, 200 psi, and 125
°C with a 1 minute ramp time and a hold time of 180 minutes. The crude product was
purified via flash column chromatography using hexanes/ethyl acetate (90:10, v/v) to afford
the title compound as a clear, pale yellow oil. 1.91:1 ds (576 mg, 67%). (Major) 1H NMR
(400MHz, CDCl3) δ=0.86-0.80 (m, 3H), 1.34 (s, 3H), 2.98-2.95 (d, J=11.45 Hz, 1H), 3.083.05 (d,J=11.45 Hz, 1H), 4.50-4.47 (dd, J=4.12 Hz, 5.95 Hz, 2H), 4.96 (s, 1H), 5.06-5.03 (dd,
J=1.37 Hz, 10.99 Hz, 1H), 5.29-5.24 (dd, J=1.37 Hz,17.40 Hz, 1H), 5.29 (s, 1H), 5.95-5.91
(dd, J=17.40 Hz, 10.99 Hz, 1H), 7.21-7.13 (m, 2H), 7.31-7.21 (m, 3H), 7.42-7.36 (m, 5H).
(Minor) 1H NMR (400MHz, CDCl3) δ=0.86-0.81 (m, 3H), 1.34 (s, 3H), 2.62-2.59 (d,
J=10.99 Hz, 1H), 3.08-3.05 (d, J=10.99 Hz, 1H), 4.44-4.42 (dd, J=3.66 Hz, 6.41 Hz, 2H),
4.88 (s, 1H), 4.96 (s, 1H), 5.02-4.99 (dd, J=1.37 Hz, 10.53 Hz, 1H), 5.22-5.18 (dd, J=17.40
Hz, 1.37 Hz, 1H), 6.05-6.00 (dd, J=10.99 Hz, 17.40 Hz, 1H), 7.21-7.13 (m, 2H), 7.31-7.21
(m, 3H), 7.42-7.36 (m, 5H). 13C NMR (100MHz, CDCl3) δ= 9.97, 9.38, 25.44, 26.31, 26.97,
28.06, 60.57, 70.55, 71.18, 79.94, 96.27, 96.86, 111.91, 112.12, 127.01, 127.16, 127.19,
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128.03, 128.15, 128.39, 128.51, 128.55, 142.46, 143.27, 143.51, 142.59, 144.54 DART
HRMS calcd for C21H25NO [M + H]+ 307.19; found 308.20282
3-benzhydryl-5-methyl-2-phenyl-5-vinyloxazolidine [49]
To a microwaveable test tube was added 3Å molecular sieves (150.0 mg). The tube
was charged with amino alcohol 60 (130 mg, 0.487 mmol) and benzaldehyde (104 mg, 0.974
mmol). The vial was sealed with a reusable cap and then placed into the microwave reactor.
The reaction was carried out with the following input parameters: 300 watts, 200 psi, and 125
°C with a 1 minute ramp time and a hold time of 15 minutes. The crude product was purified
via flash column chromatography using hexanes/ethyl acetate/TEA (90:10:0.01, v/v) to
afford the title compound as a clear, pale yellow oil. 1.71:1 ds (118 mg, 69%). (Major) 1H
NMR (400MHz, CDCl3) δ=1.39 (s, 3H), 2.85-2.83 (d, J=10.53 Hz, 1H), 3.07-3.05 (d,
J=10.53 Hz, 1H), 4.99 (s, 1H), 5.06-5.05 (d, J=11.34 Hz, 1H), 5.32-5.27 (d, J=19.23 Hz, 1H),
5.29 (s, 1H), 6.01-5.94 (dd, J=17.86 Hz, 8.93 Hz, 1H), 7.15-7.05 (m, 5H), 7.37-7.21 (m, 7H),
7.49-7.45 (m, 3H). (Minor) 1H NMR (400MHz, CDCl3) δ=1.34 (s, 3H), 2.54-2.51 (d, J=9.62
Hz, 1H) 3.29-3.26 (d, J=9.62 Hz, 1H), 4.83 (s, 1H), 5.10-5.07 (dd, J=1.37 Hz, 11.91 Hz, 1H),
5.26-5.22 (dd, J=1.37 Hz, 17.40 Hz, 1H), 5.29 (s, 1H), 6.14-6.07 (dd, J=10.99 Hz, 17.40 Hz,
1H), 7.15-7.05 (m, 5H), 7.37-7.21 (m, 7H), 7.49-7.45 (m, 3H). 13C NMR (100MHz, CDCl3)
δ=25.03, 26.56, 58.78, 59.43, 67.19, 68.81, 80.41, 81.02, 94.93, 95.19, 112.38, 112.50,
126.84, 126.96, 127.23, 127.39, 127.85, 128.03, 128.07, 128.11, 128.18, 128.22, 128.38,
128.48, 128.54, 128.58, 128.70, 129.28, 129.74, 139.81, 140.93, 141.622, 141.98, 141.98,
142.49, 143.91. DART HRMS calcd for C25H25NO [M + H]+ 355.19; found 356.20657
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3-benzhydryl-5-methyl-2-(4-methoxyphenyl)-5-vinyloxazolidine [61]
To a microwaveable test tube was added 3Å molecular sieves (150.0 mg). The tube
was charged with amino alcohol 60 (117 mg, 0.438 mmol) and p-anisaldehyde (119 mg,
0.876 mmol). The vial was sealed with a reusable cap and then placed into the microwave
reactor. The reaction was carried out with the following input parameters: 300 watts, 200
psi, and 125 °C with a 1 minute ramp time and a hold time of 300 minutes. The crude
product was purified via flash column chromatography using hexanes/ethyl acetate (85:15,
v/v) to afford the title compound as a clear, pale yellow oil. 1.57:1ds (114 mg, 68%). (Major)
1

H NMR (400MHz, CDCl3) δ= 1.42 (s, 3H), 2.78-2.75 (d, J=10.53 Hz, 1H), 3.08-3.05 (d,

J=10.53 Hz, 1H), 3.78 (s, 3H), 4.95 (s, 1H), 5.06-5.03 (dd, J=10.53 Hz, 1.37 Hz, 1H), 5.21 (s,
1H), 5.29-5.24 (dd, J=17.40 Hz, 1.37 Hz, 1H), 5.99-5.92 (dd, J=17.40 Hz, 10.53 Hz, 1H),
6.82-6.80 (m, 2H), 7.22-7.31 (m, 12H) (Minor) 1H NMR (400MHz, CDCl3) δ= 1.32 (s, 3H),
2.49-2.47 (d, J=9.62 Hz, 1H), 3.28-3.25 (d, J=9.62 Hz, 1H), 3.78 (s, 3H), 4.82 (s, 1H), 5.06
(s, 1H), 5.12-5.09 (dd, J=10.53 Hz, 1.37 Hz, 1H), 5.29-5.24 (dd, J=17.40 Hz, 1.37 Hz, 1H),
6.17-6.10 (dd, J=17.40 Hz, 10.53 Hz, 1H), 6.82-6.80 (m, 2H), 7.22-7.31 (m, 12H). 13C NMR
(100MHz, CDCl3) δ=25.43, 27.03, 53.10, 55.36, 57.69, 59.12, 66.10, 68.21,80.29, 80.72,
94.25, 94.93, 112.42, 112.47, 113.63, 113.71, 126.91, 127.26, 127.42, 127.98, 128.02,
128.20, 128.34, 128.38, 128.45, 128.91, 129.18, 129.50, 129.88, 130.15, 139.36, 141.15,
142.02, 142.47, 143.76, 144.04, 159.68, 159.99. DART HRMS calcd for C26H27NO2 [M +
H]+ 385.12; found 386.212004.

38

3-benzhydryl-5-methyl-2-(3-methoxyphenyl)-5-vinyloxazolidine [62]
To a microwaveable test tube was added 3Å molecular sieves (150.0 mg). The tube
was charged with amino alcohol 60 (114 mg, 0.425 mmol) and m-anisaldehyde (116 mg,
0.850 mmol). The vial was sealed with a reusable cap and then placed into the microwave
reactor. The reaction was carried out with the following input parameters: 300 watts, 200
psi, and 125 °C with a 1 minute ramp time and a hold time of 300 minutes. The crude
mixture was treated with sodium borohydride (16.0 mg, 0.425 mmol) and allowed to react
for 20 minutes. The reaction was quenched with Amberlyst-21. The crude mixture was then
purified via flash column chromatography using hexanes/ethyl acetate (99:5, v/v) to afford
the title compound as a clear, pale yellow oil. 1.94:1ds (116 mg, 71%). (Major) 1H NMR
(400MHz, CDCl3) δ=1.38 (s,3H), 2.86-2.84 (d, J=10.53 Hz, 1H), 3.06 (d, J=10.53 Hz, 1H),
3.77 (s, 3H), 5.01 (s, 1H), 5.08-5.05 (m, 1H), 5.32-5.28 (m,1H), 5.30 (s, 1H), 6.02-5.94 (dd,
J=17.40 Hz, 10.99 Hz, 1H),6.78 (m, 2H), 7.45-7.04 (m, 12H) (Minor) 1H NMR (400MHz,
CDCl3) δ=1.35 (s,3H), 2.55-2.52 (d, J=10.07 Hz, 1H), 3.29-3.26 (d, J=10.07 Hz, 1H), 3.75 (s,
3H), 4.85 (s, 1H), 5.11-5.08 (m, 1H), 5.13, (s, 1H), 5.28-5.23 (m, 1H), 6.14-6.07 (dd, J=17.40
Hz, 10.53 Hz, 1H), 7.45-7.04 (m, 14H). 13C NMR (100MHz, CDCl3) δ=26.06, 27.14, 55.27,
58.76, 59.43, 67.31, 69.06, 80.74, 81.13, 94.73, 95.13, 112.29, 112.55, 112.21, 113.65,
113.73, 114.48, 120.27, 121.06, 126.87, 127.02, 127.24, 127.42, 128.01, 128.06, 128.27,
128.37, 128.41, 128.50, 128.68, 129.15, 129.18, 129.29, 130.15, 132.50, 137.71, 139.77,
141.39, 141.68, 141.99, 142.64, 142.75, 143.90, 143.96. DART HRMS calcd for C26H27NO2
[M + H]+ 385.12; found 386.21860
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3-benzhydryl-5-methyl-2-(4-methylphenyl)-5-vinyloxazolidine [64]
To a microwaveable test tube was added 3Å molecular sieves (150.0 mg). The tube
was charged with amino alcohol 60 (127 mg, 0.474 mmol) and p-tolualdehyde (114 mg,
0.948 mmol). The vial was sealed with a reusable cap and then placed into the microwave
reactor. The reaction was carried out with the following input parameters: 300 watts, 200
psi, and 125 °C with a 1 minute ramp time and a hold time of 300 minutes. The crude
mixture was treated with sodium borohydride (17.9 mg, 0.474 mmol) and allowed to react
for 20 minutes. The reaction was quenched with Amberlyst-21. The crude mixture was then
purified via flash column chromatography using hexanes/ethyl acetate /TEA (99:1:0.01, v/v)
to afford the title compound as a clear, pale yellow oil. 1.59:1ds (136 mg, 78%). (Major) 1H
NMR (400MHz, CDCl3) δ=1.39 (s, 3H), 2.31 (s, 3H), 2.82-2.79 (d, J=10.53 Hz, 1H), 3.063.03 (d, J=10.53 Hz, 1H), 4.99 (s, 1H), 5.06-5.03 (dd, J= 10.99 Hz, 1.37 Hz, 1H), 5.26 (s,
1H), 5.30-5.25 (dd, J= 17.40 Hz, 1.37 Hz, 1H), 6.00-5.93 (dd, J= 17.40 Hz, 10.99 Hz, 1H),
7.39-7.08 (m, 14H) (Minor) 1H NMR (400MHz, CDCl3) δ=1.33 (s, 3H), 2.31(s, 3H), 2.512.49 (d, J=9.62 Hz, 1H), 3.27-3.25 (d, J=9.62 Hz, 1H), 4.85 (s, 1H), 5.09 (s, 1H), 5.10 – 5.07
(dd, J=10.99 Hz, 0.92 Hz, 1H), 5.27-5.23 (dd, J=17.40 Hz, 1.37 Hz, 1H), 6.15-6.08 (dd,
J=17.40 Hz, 10.53 Hz, 1H), 7.39-7.08 (m, 14H). 13C NMR (100MHz, CDCl3) δ=19.19,
21.08, 26.89, 36.90, 59.13, 68.35, 80.31, 80.71, 95.02, 112.30, 126.88, 127.22, 127.78,
128.00, 128.22, 128.31, 128.43, 128.52, 128.87, 128.94, 128.52, 136.68, 137.84, 141.32,
142.65, 143.95. DART HRMS calcd for C26H27NO [M + H]+ 369.21; found 370.217089.
3-benzhydryl-5-methyl-2-(3-methylphenyl)-5-vinyloxazolidine [65]
To a microwaveable test tube was added 3Å molecular sieves (150.0 mg). The tube
was charged with amino alcohol 60 (122 mg, 0.456 mmol) and m-tolualdehyde (110 mg,
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0.912 mmol). The vial was sealed with a reusable cap and then placed into the microwave
reactor. The reaction was carried out with the following input parameters: 300 watts, 200
psi, and 125 °C with a 1 minute ramp time and a hold time of 300 minutes. The crude
mixture was treated with sodium borohydride (16.0 mg, 0.456 mmol) and allowed to react
for 20 minutes. The reaction was quenched with Amberlyst-21. The crude mixture was then
purified via flash column chromatography using hexanes/ethyl acetate /TEA (99:1:0.01, v/v)
to afford the title compound as a clear, pale yellow oil. 1.60:1 ds (135 mg, 80%). (Major) 1H
NMR (400MHz, CDCl3) δ=1.40 (s, 3H), 2.30 (s, 3H), 2.82-2.80 (d, J= 10.99 Hz, 1H), 3.083.05 (d, J=10.99 Hz, 1H), 4.97 (s, 1H), 5.07-5.04 (dd, J= 10.99 Hz, 1.37 Hz, 1H), 5.24 (s,
1H), 5.31-5.26 (dd, J=17.40 Hz, 1.37 Hz, 1H) 6.00-5.93 (dd, 17.40 Hz, 10.53 Hz, 1H), 7.367.03 (m, 14H). (Minor) 1H NMR (400MHz, CDCl3) δ=1.34 (s, 3H), 2.29 (s, 3H), 2.53-2.50
(d, J= 10.07 Hz, 1H) 3.28-3.26 (d, J=10.07 Hz, 1H), 4.83 (s, 1H), 5.09 (s, 1H), 5.11-5.08 (dd,
J=10.99 Hz, 1.37 Hz, 1H), 5.26-5.22 (dd, J- 17.40 Hz, 1.37 Hz, 1H), 5.24 (s, 1H), 6.16-6.09
(dd, J=17.40 Hz, 10.53 Hz, 1H), 7.36 – 7.03 (m, 14H). 13C NMR (100MHz, CDCl3) δ=
21.52, 25.45, 27.08, 29.72, 53.29, 58.78, 59.49, 67.23, 68.90, 80.55, 80.73, 94.99, 95.44,
112.35, 112.47, 124.86, 125.59, 126.78, 126.90, 127.21, 127.36, 127.95, 128.02, 128.06,
128.15, 128.34, 128.45, 128.63, 128.76, 128.88, 129.32, 137.58, 137.63, 139.54, 139.77,
140.73, 141.55, 142.04, 142.59, 143.84, 143.91. DART HRMS calcd for C26H27NO [M + H]+
369.21; found 370.22330.
3-benzhydryl-5-methyl-2-(4-chlorophenyl)-5-vinyloxazolidine [66]
To a microwaveable test tube was added 3Å molecular sieves (150.0 mg). The tube
was charged with amino alcohol 60 (123 mg, 0.459 mmol) and 4-chlorobenzaldehyde (129
mg, 0.918 mmol). The vial was sealed with a reusable cap and then placed into the
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microwave reactor. The reaction was carried out with the following input parameters: 300
watts, 200 psi, and 125 °C with a 1 minute ramp time and a hold time of 90 minutes. The
crude mixture was treated with sodium borohydride (17.3 mg, 0.459 mmol) and allowed to
react for 20 minutes. The reaction was quenched with Amberlyst-21. The crude mixture was
then purified via flash column chromatography using hexanes/ethyl acetate /TEA (99:1:0.01,
v/v) to afford the title compound as a clear, pale yellow oil. 2.90:1 ds (135 mg, 80%).
(Major) 1H NMR (400MHz, CDCl3) δ=1.36 (s, 3H), 2.88-2.85 (d, J=10.99 Hz, 1H), 3.063.03 (d, J=10.99 Hz, 1H), 4.96 (s, 1H), 5.08-5.07 (m, 1H), 5.28 (s, 1H), 5.32-5.29 (m, 1H),
6.01-5.94 (dd, J=10.53 Hz, 17.40 Hz, 1H), 7.38-7.07 (m, 14H). (Minor) 1H NMR (400MHz,
CDCl3) δ=1.36 (s, 3H), 2.58-2.55 (d, J=10.07 Hz, 1H), 3.30-3.28 (d, J=10.07 Hz, 1H), 4.78
(s, 1H), 5.10-5.07 (m, 1H), 5.12, (s, 1H), 5.24-5.20 (m, 1H), 6.11-6.04 (dd, J=17.40 Hz,
10.99 Hz, 1H), 7.38-7.07 (m, 14H). 13C NMR (100MHz, CDCl3) δ=25.80, 27.20, 59.59,
60.15, 68.73, 69.94, 80.93, 81.35, 94.32, 94.93, 112.63, 112.77, 127.11, 127.23, 127.39,
127.55, 128.15, 128.31, 128.39, 128.47, 128.60, 128.96, 128.26, 129.95, 133.84, 134.13,
138.76, 139.84, 140.35, 141.78, 142.00, 142.47, 143.74, 143.80. DART HRMS calcd for
C25H24ClNO [M + H]+ 389.15; found 390.16519
3-benzhydryl-5-methyl-2-(3-chlorophenyl)-5-vinyloxazolidine [67]
To a microwaveable test tube was added 3Å molecular sieves (150.0 mg). The tube
was charged with amino alcohol 60 (120 mg, 0.448 mmol) and 3-chlorobenzaldehyde (126
mg, 0.896 mmol). The vial was sealed with a reusable cap and then placed into the
microwave reactor. The reaction was carried out with the following input parameters: 300
watts, 200 psi, and 125 °C with a 1 minute ramp time and a hold time of 90 minutes. The
crude mixture was treated with sodium borohydride (16.9 mg, 0.448 mmol) and allowed to
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react for 20 minutes. The reaction was quenched with Amberlyst-21. The crude mixture was
then purified via flash column chromatography using hexanes/ethyl acetate /TEA (95:5:0.01,
v/v) to afford the title compound as a clear, pale yellow oil. 1.66:1 ds (156 mg, 90%).
(Major) 1H NMR (400MHz, CDCl3) δ= 1.37 (s, 3H), 2.90 – 2.88 (d, J=10.53 Hz, 1H), 3.073.04 (d, J= 10.53 Hz, 1H), 4.96 (s, 1H), 5.11-5.08 (dd, J= 10.53 Hz, 1.83 Hz, 1H), 5.27 (s,
1H), 5.33-5.27 (dd, J=17.40 Hz, 1.37 Hz, 1H), 6.01-5.94 (dd, J=17.40 Hz, 10.53 Hz, 1H),
7.41-7.06 (m, 14). (Minor) 1H NMR (400MHz, CDCl3) δ=1.37 (s, 3H), 2.60-2.58 (d, J=10.07
Hz, 1H), 3.32-3.29 (d, J=10.07 Hz, 1H), 4.78 (s, 1H), 5.11-5.08 (dd, J=10.53 Hz, 1.37 Hz,
1H), 5.12 (s, 1H), 5.24-5.20 (dd, J= 17.40 Hz, 1.37 Hz, 1H), 6.11-6.04 (dd, J= 17.40 Hz,
10.53 Hz, 1H), 7.41-7.06 (m, 14H). 13C NMR (100MHz, CDCl3) δ= 25.45, 27.48, 60.01,
60.27, 69.33, 70.29, 80.77, 81.39, 94.64, 94.96, 112.56, 112.75, 125.96, 126.60, 127.13,
127.24, 127.29, 127.45, 127.87, 128.07, 128.10, 128.13, 128.29, 128.44, 128.56, 128.62,
128.71, 129.32, 130.07, 132.48, 133.88, 133.94, 140.65, 141.68, 142.14, 142.30, 142.41,
143.53, 143.70. DART HRMS calcd for C25H24ClNO [M + H]+ 389.15; found 390.16580
3-benzhydryl-5-methyl-2-(4-nitrophenyl)-5-vinyloxazolidine [68]
To a microwaveable test tube was added 3Å molecular sieves (150.0 mg). The tube
was charged with amino alcohol 60 (131mg, 0.489 mmol) and 4-nitrobenzaldehyde (148 mg,
0.978 mmol). The vial was sealed with a reusable cap and then placed into the microwave
reactor. The reaction was carried out with the following input parameters: 300 watts, 200
psi, and 125 °C with a 1 minute ramp time and a hold time of 90 minutes. The crude product
was purified via flash column chromatography using hexanes/ethyl acetate (95:5, v/v) to
afford the title compound as a clear, pale yellow oil. 1.84:1 ds (160 mg, 82%). (Major) 1H
NMR (400MHz, CDCl3) δ=1.34 (s,3H), 2.97(d, J=10.99 Hz, 1H), 3.06(d, J=11.45 Hz, 1H),
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4.97 (s,1H), 5.14-5.11(dd, J=10.99 Hz, 1.37 Hz, 1H), 5.36-5.31(dd, J=17.40 Hz, 0.92 Hz,
1H), 5.38 (s, 1H), 6.02-5.98 (dd, J=16.94 Hz,10.99 Hz, 1H), 7.08-7.02 (m, 3H), 7.27-7.20
(m, 3H), 7.33-7.27 (m, 2H), 7.44-7.42 (m, 2H), 7.53-7.51 (m, 2H), 8.07-8.04 (m, 2H).
(Minor) 1H NMR (400MHz, CDCl3) δ=1.41(s, 3H), 2.69-2.67(d, J=10.07 Hz, 1H), 3.383.35(d, J=10.53 Hz, 1H), 4.75 (s, 1H), 5.11-5.08 (d, J=0.92 Hz, 10.99 Hz, 1H), 5.22-5.18 (d,
J=0.92 Hz, 17.40 Hz, 1H), 5.27 (s, 1H), 6.08-6.01 (dd, J=10.99 Hz, 16.49 Hz, 1H), 7.00 (m,
2H), 7.17 (m, 2H), 7.27-7.24 (m, 2H), 7.39-7.37 (m, 3H), 7.47-7.45 (m, 2H), 7.81-7.79 (d,
J=6.87 Hz, 1H), 8.02-8.00 (d, J=8.70 Hz, 2H).

13

C NMR (100MHz, CDCl3) δ=25.87, 27.07,

61.05, 61.35, 71.08, 71.32, 81.55, 81.92, 94.83, 112.87, 112.99, 123.09, 123.19, 127.41,
127.47, 127.55, 127.91, 128.15, 128.26, 128.30, 128.40, 128.54, 128.75, 129.21, 130.14,
141.39, 141.49, 142.16, 142.47, 143.20, 143.43, 147.59, 147.65, 148.05, 149.06. DART
HRMS calcd for C25H24N2O3 [M + H]+ 400.18; found 401.186518
3-benzhydryl-5-methyl-2-(3-nitrophenyl)-5-vinyloxazolidine [69]
To a microwaveable test tube was added 3Å molecular sieves (150.0 mg). The tube
was charged with amino alcohol 60 (145 mg, 0.542 mmol) and 3-nitrobenzaldehyde (164 mg,
1.09 mmol). The vial was sealed with a reusable cap and then placed into the microwave
reactor. The reaction was carried out with the following input parameters: 300 watts, 200
psi, and 125 °C with a 1 minute ramp time and a hold time of 90 minutes. The crude product
was purified via flash column chromatography using hexanes/ethyl acetate (80:20, v/v) to
afford the title compound as a clear, pale yellow oil. 2.09:1 ds (152 mg, 71%). (Major) 1H
NMR (400MHz, CDCl3) δ=1.40 (s, 3H), 2.94-2.91 (d, J=10.99 Hz, 1H), 3.13-3.10 (d,
J=10.99 Hz, 1H), 4.92 (s, 1H), 5.14-5.11 (m, 1H), 5.36-5.35 (m, 1H), 5.39 (s, 1H), 6.02-5.95
(dd, J=17.40 Hz, 10.53 Hz, 1H), 7.02-6.96 (m, 2H), 7.23-7.19 (m, 3H), 7.35-7.26 (m, 3H),
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7.47-7.39 (m, 2H), 7.68-7.66 (m, 1H), 7.80-7.78 (m, 1H), 8.01-7.99 (m, 1H), 8.12 (s, 1H)
(Minor) 1H NMR (400MHz, CDCl3) δ=1.40 (s, 3H), 2.67-2.64 (d, J=10.07 Hz),3.40-3.38 (d,
J=10.07 Hz, 1H), 4.71 (s, 1H), 5.25-5.20 (m, 1H), 5.24 (s, 1H), 5.36-5.31 (m, 1H), 6.12-6.05
(dd, J=17.40 Hz, 10.53 Hz, 1H), 6.97-6.93 (m, 3H), 7.15-7.13 (m, 3H),7.28-7.23 (m, 2H)
7.44-7.39, (m, 2H),7.57-7.54 (m, 1H), 7.65-7.63 (m, 1H), 7.99- 7.96 (m, 1H), 8.05 (s, 1H).
13

C NMR (100MHz, CDCl3) δ=27.03, 61.08, 71.25, 81.39, 94.31, 112.73, 122.86, 122.93,

127.36, 127.39, 127.86, 128.29, 128.33, 128.76, 133.89, 141.79, 142.43, 143.20, 143.98,
148.02. DART HRMS calcd for C25H24N2O3 [M + H]+ 400.18; found 401.18240
1-(1-benzhydryl-5-ethyl-pyrrolidin-3-yl)ethanone [48]
According to the general procedure, oxazolidine 47 (75 mg, 0.246 mmol)
and BF3•OEt2 (8.7 mg, 0.062 mmol) were reacted for 15 minutes. The general workup
afforded the title compound as a pale yellow oil (67 mg, 88%). 1H NMR (400MHz, CDCl3)
δ= 0.75 (t, J=7,3 Hz, 3H), 1.19 (m, 1H), 1.43 (m, 1H), 1.73 (m, 1H), 2.09 (m, 1H), 2.10 (s,
3H), 2.49 (dd, J=9.2, 7.8 Hz, 1H), 2.80 (sept, J=4.6 Hz, 1H), 3.05 (m, 2H), 4.78 (s, 1H), 7.25
(m, 10H). 13C NMR (100MHz, CDCl3) δ= 10.4, 25.2, 29.0, 31.5, 49.8, 52.3, 62.0, 70.0, 126.9
127.0, 128.1, 128.2, 128.3, 128.8, 141.5, 143.6, 209.6. DART HRMS calcd for C21H25NO [M
+ H]+ 307.19; found 308.20861
1-(1-benzhydryl-5-phenyl-pyrrolidin-3-yl)ethanone [50]
According to the general procedure, oxazolidine 49 (47 mg, 0.132 mmol)
and BF3•OEt2 (4.7 mg, 0.033 mmol) were reacted for 15 minutes. The general workup
afforded the title compound as a pale yellow oil (41 mg, 87%). 1H NMR (400MHz, CDCl3)
δ= 1.92-1.84 (m, 1H), 2.08 (s, 3H), 2.42-2.36 (m, 2H), 3.37-3.27 (m, 2H), 3.68-3.64 (m, 1H),
4.80 (s, 1H), 7.40-7.06 (m, 15). 13C NMR (100MHz, CDCl3) δ= 29.21, 36.60, 49.40, 50.62,
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64.47, 67.13, 126.62, 127.04, 127.28, 127.47, 127.88, 128.13, 128.54, 129.91, 138.44,
142.27, 143.96, 208.90. DART HRMS calcd for C25H25NO [M + H]+ 355.19; found
356.21197
1-(1-benzhydryl-5-(4-methoxyphenyl)pyrrolidin-3-yl)ethanone [70]
According to the general procedure, oxazolidine 62 (118 mg, 0.307 mmol)
and BF3•OEt2 (10.9 mg, 0.077 mmol) were reacted for 12 hours. The general workup
afforded the title compound as a pale yellow oil (103 mg, 96%). 1H NMR (400MHz, CDCl3)
δ=1.93-1.86 (m, 1H), 2.10 (s, 3H), 2.42-2.35 (m, 2H), 3.38-3.28 (m, 2H), 3.65-3.61 (m, 1H),
3.79 (s, 3H), 4.83 (s, 1H), 6.86-6.85 (m, 2H), 7.36-7.14 (m, 12H). 13C NMR (100MHz,
CDCl3) δ=29.08, 29.60, 36.30, 49.31, 50.42, 55.06, 64.35, 67.01, 112.23, 112.79, 119.72,
126.49, 127.16, 127.76, 127.94, 128.00, 129.38, 129.77M 138.29, 142.18, 145.63, 159.70,
208.65. DART HRMS calcd for C26H27NO2 [M + H]+ 385.12; found 386.21249
1-(1-benzhydryl-5-(3-methoxyphenyl)pyrrolidin-3-yl)ethanone [71]
According to the general procedure, oxazolidine 63 (28 mg, 0.74 mmol)
and BF3•OEt2 (2.6 mg, 0.019 mmol) were reacted for 12 hours. The general workup afforded
the title compound as a pale yellow oil (23 mg, 82%). 1H NMR (400MHz, CDCl3) δ=1.931.85 (m, 1H), 2.09 (s, 3H), 2.42-2.35 (m, 2H) 3.35-3.27 (m, 2H), 3.67-3.63 (m, 1H), 3.78 (s,
3H), 4.83 (s, 1H), 6.76 (m, 1H), 6.94-6.91 (m, 2H), 7.34-7.14 (m, 11H). 13C NMR (100MHz,
CDCl3) δ=29.08, 29.64, 36.30, 49.31, 50.42, 55.06, 64.35, 67.01, 76.67, 77.00, 77.31,
112.23, 112.79, 119.72, 126.49, 127.16, 127.76, 127.94, 128.00, 129.38, 129.77, 138.29,
142.18, 145.63, 159.70, 208.65 DART HRMS calcd for C26H27NO2 [M + H]+ 385.12; found
386.21202
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1-(1-benzhydryl-5-(p-tolyl)pyrrolidin-3-yl)ethanone [72]
According to the general procedure, oxazolidine 64 (35 mg, 0.094 mmol)
and BF3•OEt2 (3.3 mg, 0.024 mmol) were reacted for 60 minutes. The general workup
afforded the title compound as a pale yellow oil (28 mg, 80%). 1H NMR (400MHz, CDCl3)
δ= 1.91-1.84 (m, 1H), 2.08 (s, 3H), 2.32 (s, 3H), 2.40-2.32 (m, 2H), 3.35-3.26 (m, 2H), 3.633.60 (m, 1H), 4.81 (s, 1H), 7.35-7.10 (m, 14H). 13C NMR (100MHz, CDCl3) δ=21.54, 29.08,
36.36, 49.33, 50.49, 64.47, 66.84, 124.40, 126.45, 127.15, 127.70, 127.74, 127.99, 128.16,
128.33, 129.83, 137.88, 138.32, 142.29, 143.69, 208.67. DART HRMS calcd for C26H27NO
[M + H]+ 369.21; found 370.21320
1-(1-benzhydryl-5-(m-tolyl)pyrrolidin-3-yl)ethanone [73]
According to the general procedure, oxazolidine 65 (19 mg, 0.052 mmol)
and BF3•OEt2 (1.8 mg, 0.013 mmol) were reacted for 60 minutes. The general workup
afforded the title compound as a pale yellow oil (16 mg, 85%). 1H NMR (400MHz, CDCl3)
δ=1.93-1.85 (m, 1H), 2.08 (s, 3H), 2.31 (s, 3H), 2.41-2.31 (m, 2H), 3.36-3.29 (m, 2H), 3.643.61 (m, 1H), 4.80 (s, 1H), 7.33-7.02 (m, 14H). 13C NMR (100MHz, CDCl3) δ=21.41, 29.10,
36.50, 49.38, 50.38, 64.40, 66.88, 124.40, 126.46, 127.03, 127.71, 128.00, 128.16, 128.28,
129.84, 137.89, 142.33, 143.72, 208.83. DART HRMS calcd for C26H27NO [M + H]+ 369.21;
found 370.21310
1-(1-benzhydryl-5-(4-chlorophenyl)pyrrolidin-3-yl)ethanone [74]
According to the general procedure, oxazolidine 66 (38 mg, 0.104 mmol)
and BF3•OEt2 (3.7 mg, 0.026 mmol) were reacted for 60 minutes. The general workup
afforded the title compound as a pale yellow oil (32 mg, 88%). 1H NMR (400MHz, CDCl3)
δ= 1.87-1.79 (m, 1H), 2.10 (s, 3H), 2.44-2.37 (m, 2H), 3.26 (m, 2H), 3.68-3.64 (m, 1H), 4.75
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(s, 1H), 7.34-7.12 (m, 14H). 13C NMR (100MHz, CDCl3) δ=24.54, 31.93, 44.62, 46.51,
59.39, 63.29, 122.06, 122.66, 123.23, 123.42, 123.53, 123.92, 124.02, 124.90, 127.81,
134.06, 137.37, 138.00, 204.48. DART HRMS calcd for C25H24ClNO [M + H]+ 389.15;
found 390.16019
1-(1-benzhydryl-5-(3-chlorophenyl)pyrrolidin-3-yl)ethanone [75]
According to the general procedure, oxazolidine 67 (62 mg, 0.159 mmol)
and BF3•OEt2 (5.6 mg, 0.040 mmol) were reacted for 60 minutes. The general workup
afforded the title compound as a pale yellow oil (54 mg, 85%). 1H NMR (400MHz, CDCl3)
δ=1.88-1.81 (m, 1H), 2.08 (s, 3H), 2.46-2.37 (m, 1H), 3.39-3.26 (m, 2H), 3.70 – 3.66 (m,
1H), 4.73 (s, 1H), 7.34-7.09 (m, 14H).

13

C NMR (100MHz, CDCl3) δ=29.70, 37.19, 49.64,

52.11, 64.83, 69.29, 125.87, 127.22, 127.41, 127.73, 127.82, 128.28, 128.62, 128.68, 129.80,
130.08, 124.57, 139.53, 142.37, 147.12, 209.37. DART HRMS calcd for C25H24ClNO [M +
H]+ 389.15; found 390.15530
1-(1-benzhydryl-5-(4-nitrophenyl)pyrrolidin-3-yl)ethanone [76]
According to the general procedure, oxazolidine 68 (92 mg, 0.230 mmol)
and BF3•OEt2 (8.2 mg, 0.058 mmol) were reacted for 16 hours. The general workup afforded
the title compound as a pale yellow oil 18:1 ds (80 mg, 87%). (Major) 1H NMR (400MHz,
CDCl3) δ= 1.85-1.78 (m, 1H), 2.11 (s, 3H), 2.54-2.45 (m, 2H), 3.37-3.29 (m, 1H), 3.46-3.43
(m, 1H), 4.70 (s, 1H), 7.04-7.02 (m, 3H), 7.19-7.16 (m, 2H), 7.26-7.24 (m, 3H), 7.33-7.30
(m, 2H), 7.38-7.36 (m, 2H), 8.05-8.03 (m, 2H). (Minor) 1H NMR (400MHz, CDCl3) δ=
0.85-1.78 (m, 1H), 2.20 (s, 3H), 3.00-2.94 (m, 2H),3.46-3.29 (m, 1H), 3.69-3.65 (m, 1H),
4.70 (s, 1H), 7.19-7.16 (m, 1H), 7.26-7.24 (m, 3H), 7.36-7.31 (m, 3H), 7.49-7.44 (m, 3H),
7.59-7.55 (m, 1H), 7.80-7.78 (m, 2H), 8.10-8.05 (m, 1H). 13C NMR (100MHz, CDCl3)
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δ=29.32, 36.95, 49.48, 53.13, 64.74, 70.61, 123.51, 126.98, 127.36, 127.80, 127.84, 128.36,
128.81, 139.84, 141.59, 146.66, 152.78, 208.73. DART HRMS calcd for C25H24N2O3 [M +
H]+ 400.18; found 401.18420
1-(1-benzhydryl-5-(3-nitrophenyl)pyrrolidin-3-yl)ethanone [77]
According to the general procedure, oxazolidine 69 (105 mg, 0.261 mmol)
and BF3•OEt2 (9.3 mg, 0.065 mmol) were reacted for 15 minutes. The general workup
afforded the title compound as a pale yellow oil 17:1ds (95 mg, 90%). (Major) 1H NMR
(400MHz, CDCl3) δ=1.89-1.82 (m, 1H), 2.11 (s, 3H), 2.59-2.47 (m, 2H), 3.40-3.30 (m, 1H),
3.49-3.45 (m, 1H), 3.88-3.84 (m, 1H), 4.69 (s, 1H), 7.00-6.98 (m, 3H), 7.17 (m, 2H), 7.24
(m, 1H), 7.33-7.29 (m, 5H) 7.50-7.46 (m, 1H), 7.97 – 7.94 (m, 1H), 8.06-8.04 (m, 1H).
(Minor) 1H NMR (400MHz, CDCl3) δ=1.65 (m, 1H), 2.21 (s, 3H), 2.36-2.27 (m, 2H), 2.712.59 (m, 1H), 3.01-2.92 (m, 1H), 3.47-3.45 (m, 1H), 3.71-3.67 (m, 1H), 7.33-6.98 (m, 5H),
7.59-7.55 (m, 6H), 7.75-7.73 (m, 1H), 8.02-7.96 (m, 2H). 13C NMR (100MHz, CDCl3)
δ=29.43, 37.15, 49.46, 53.66, 64.76, 71.46, 121.68, 122.29, 127.02, 127.43, 127.92, 128.38,
128.53, 128.75, 129.13, 129.53, 130.14, 132.44, 133.38, 140.48, 141.70, 147.58, 148.30,
208.21. DART HRMS calcd for C25H24N2O3 [M + H]+ 400.18; found 401.18240
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